MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study (Q28285807)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study
scientific article

    Statements

    MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study (English)
    0 references
    Antonio Albarran Y Carvajal
    0 references
    Alfonso de la Garza
    0 references
    Benitez Jose Cecilio Cruz Quiroz
    0 references
    Eduardo Vazquez Zea
    0 references
    Ismael Díaz Estrada
    0 references
    Ernesto Mendez Fuentez
    0 references
    Mario López Contreras
    0 references
    Alejandro Andrade-Manzano
    0 references
    Santiago Padilla
    0 references
    Axel Ramírez Varela
    0 references
    Ricardo Rosales
    0 references
    2007
    0 references
    0 references
    21
    0 references
    1
    0 references
    47-59
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit